Travere Therapeutics

ISIN US89422G1076

WKN A2QHYP

Market cap (in EUR)

2,730 m

Country

United States

Sector

Healthcare

Dividend yield

0.00%

Overview

Description

Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 7, 2008 and is headquartered in San Diego, CA.

Show more Show less

Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals United States

Financials

Key metrics

Market capitalisation, EUR	2,730 m
EPS, EUR	-0.98
P/B ratio	43.3
P/E ratio	-
Dividend yield	0.00%

Income statement (2024)

Revenue, EUR	216 m
Net income, EUR	-296 m
Profit margin	-137.51%

What ETF is Travere Therapeutics in?

There are 19 ETFs which contain Travere Therapeutics. All of these ETFs are listed in the table below. The ETF with the largest weighting of Travere Therapeutics is the L&G Pharma Breakthrough UCITS ETF.

ETF	Weight	Investment focus	Fund size (in m EUR)
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (acc)	0.05%	Equity United States Small Cap	56
UBS MSCI USA Select Factor Mix UCITS ETF hEUR acc	0.01%	Equity United States Multi-Factor Strategy	8
SPDR MSCI All Country World Investable Market UCITS ETF (Acc)	0.00%	Equity World	4,171
UBS MSCI USA Select Factor Mix UCITS ETF USD acc	0.01%	Equity United States Multi-Factor Strategy	95
SPDR MSCI World Small Cap UCITS ETF	0.03%	Equity World Small Cap	1,457
Xtrackers Portfolio UCITS ETF 1C	0.00%	Equity World Multi-Asset Strategy	681
L&G Russell 2000 US Small Cap Quality UCITS ETF	0.09%	Equity United States Small Cap	179
Xtrackers Russell 2000 UCITS ETF 1C	0.11%	Equity United States Small Cap	1,898
SPDR MSCI All Country World Investable Market UCITS ETF (Dist)	0.00%	Equity World	74
UBS MSCI USA Select Factor Mix UCITS ETF USD dis	0.01%	Equity United States Multi-Factor Strategy	29
UBS MSCI USA Select Factor Mix UCITS ETF hCHF acc	0.01%	Equity United States Multi-Factor Strategy	25
iShares MSCI USA Small Cap ESG Enhanced CTB UCITS ETF USD (Acc)	0.02%	Equity United States Small Cap	1,865
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)	0.25%	Equity United States Health Care Biotech	45
iShares MSCI World Small Cap UCITS ETF	0.03%	Equity World Small Cap	6,481
iShares Nasdaq US Biotechnology UCITS ETF	0.25%	Equity United States Health Care Biotech	740
SPDR MSCI World Small Cap UCITS ETF USD Unhedged (Dist)	0.03%	Equity World Small Cap	25
SPDR Russell 2000 US Small Cap UCITS ETF	0.11%	Equity United States Small Cap	4,102
ODDO BHF Global Equity Active UCITS ETF (Acc)	0.00%	Equity World Social/Environmental	4
L&G Pharma Breakthrough UCITS ETF	4.04%	Equity World Health Care Innovation	18

Change your settings